A detailed history of Virtus ETF Advisers LLC transactions in Xencor Inc stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 4,323 shares of XNCR stock, worth $108,247. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,323
Previous 4,248 1.77%
Holding current value
$108,247
Previous $80,000 7.5%
% of portfolio
0.04%
Previous 0.04%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.7 - $21.65 $1,177 - $1,623
75 Added 1.77%
4,323 $86,000
Q2 2024

Aug 14, 2024

BUY
$18.21 - $24.5 $2,931 - $3,944
161 Added 3.94%
4,248 $80,000
Q1 2024

May 15, 2024

SELL
$18.65 - $26.52 $5,147 - $7,319
-276 Reduced 6.33%
4,087 $90,000
Q4 2023

Feb 15, 2024

BUY
$16.53 - $21.42 $10,595 - $13,730
641 Added 17.22%
4,363 $92,000
Q3 2023

Nov 07, 2023

SELL
$20.08 - $25.39 $7,529 - $9,521
-375 Reduced 9.15%
3,722 $74,000
Q2 2023

Aug 14, 2023

BUY
$24.77 - $29.9 $13,673 - $16,504
552 Added 15.57%
4,097 $102,000
Q1 2023

May 15, 2023

SELL
$25.95 - $36.95 $35,447 - $50,473
-1,366 Reduced 27.82%
3,545 $98,000
Q4 2022

Feb 14, 2023

SELL
$24.79 - $30.86 $7,660 - $9,535
-309 Reduced 5.92%
4,911 $127,000
Q3 2022

Nov 14, 2022

BUY
$24.62 - $32.44 $861 - $1,135
35 Added 0.68%
5,220 $136,000
Q2 2022

Aug 12, 2022

BUY
$19.74 - $29.01 $11,705 - $17,202
593 Added 12.91%
5,185 $142,000
Q1 2022

May 16, 2022

SELL
$26.68 - $41.63 $7,390 - $11,531
-277 Reduced 5.69%
4,592 $123,000
Q4 2021

Feb 14, 2022

SELL
$33.67 - $43.44 $27,676 - $35,707
-822 Reduced 14.44%
4,869 $195,000
Q3 2021

Nov 15, 2021

SELL
$30.65 - $35.68 $9,225 - $10,739
-301 Reduced 5.02%
5,691 $186,000
Q2 2021

Aug 10, 2021

SELL
$34.33 - $44.68 $18,915 - $24,618
-551 Reduced 8.42%
5,992 $207,000
Q1 2021

May 17, 2021

BUY
$40.81 - $53.88 $4,774 - $6,303
117 Added 1.82%
6,543 $282,000
Q4 2020

Feb 12, 2021

SELL
$36.63 - $47.63 $161,428 - $209,905
-4,407 Reduced 40.68%
6,426 $280,000
Q3 2020

Nov 13, 2020

SELL
$30.09 - $43.02 $44,894 - $64,185
-1,492 Reduced 12.11%
10,833 $420,000
Q2 2020

Aug 05, 2020

BUY
$27.76 - $33.42 $74,729 - $89,966
2,692 Added 27.95%
12,325 $399,000
Q1 2020

May 14, 2020

SELL
$20.69 - $37.79 $28,986 - $52,943
-1,401 Reduced 12.7%
9,633 $288,000
Q4 2019

Feb 13, 2020

BUY
$32.75 - $41.43 $97,234 - $123,005
2,969 Added 36.81%
11,034 $379,000
Q3 2019

Nov 12, 2019

SELL
$33.73 - $46.27 $15,144 - $20,775
-449 Reduced 5.27%
8,065 $272,000
Q2 2019

Aug 13, 2019

BUY
$29.6 - $40.93 $40,078 - $55,419
1,354 Added 18.91%
8,514 $348,000
Q1 2019

May 14, 2019

SELL
$27.85 - $38.09 $29,771 - $40,718
-1,069 Reduced 12.99%
7,160 $222,000
Q4 2018

Feb 05, 2019

SELL
$32.39 - $42.05 $106,239 - $137,924
-3,280 Reduced 28.5%
8,229 $298,000
Q3 2018

Nov 14, 2018

SELL
$35.69 - $47.65 $294,906 - $393,731
-8,263 Reduced 41.79%
11,509 $449,000
Q2 2018

Aug 10, 2018

SELL
$28.41 - $42.41 $448,366 - $669,314
-15,782 Reduced 44.39%
19,772 $732,000
Q1 2018

May 14, 2018

BUY
$21.18 - $33.78 $407,503 - $649,927
19,240 Added 117.94%
35,554 $1.07 Million
Q4 2017

Feb 14, 2018

BUY
$19.29 - $24.83 $8,352 - $10,751
433 Added 2.73%
16,314 $358,000
Q3 2017

Nov 14, 2017

BUY
$19.61 - $23.35 $28,473 - $33,904
1,452 Added 10.06%
15,881 $364,000
Q2 2017

Aug 14, 2017

BUY
N/A
14,429
14,429 $305,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.49B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.